Watts Ryan J. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
65
Insider Sells Sum
$37.41M

Insider Activity of Watts Ryan J.

According to the SEC Form 4 filings, Watts Ryan J., being in a position of

  1. President and CEO at Denali Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35198 shares for $580,767,
    over all time since 2018-08-29, has bought 0 shares, and sold 1664515 shares for $45.42M.

Biography of Watts Ryan J.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $580,7671100

Comparison of Insiders on Amount of Buys and Sells

2026-01-06SaleDenali Therapeutics Inc.
DNLI
President and CEO
35,198
0.0232%
$16.50$580,767+19.44%
2025-07-09SaleDenali Therapeutics Inc.
DNLI
President and CEO
495,282
0.3409%
$15.00$7.43M+21.07%
2025-01-07SaleDenali Therapeutics Inc.
DNLI
President and CEO
7,650
0.0052%
$20.81$159,197-28.26%
2025-01-06SaleDenali Therapeutics Inc.
DNLI
President and CEO
29,266
0.0208%
$20.22$591,759-23.34%
2024-10-18SaleDenali Therapeutics Inc.
DNLI
President and CEO
40,000
0.028%
$27.69$1.11M-44.84%
2024-08-20SaleDenali Therapeutics Inc.
DNLI
President and CEO
2,260
0.0016%
$23.79$53,765-17.99%
2024-02-13SaleDenali Therapeutics Inc.
DNLI
President and CEO
9,589
0.0065%
$17.29$165,794+29.66%
2024-01-09SaleDenali Therapeutics Inc.
DNLI
President and CEO
7,818
0.0057%
$19.78$154,640+9.12%
2024-01-05SaleDenali Therapeutics Inc.
DNLI
President and CEO
17,483
0.0127%
$19.43$339,695+11.53%
2023-08-21SaleDenali Therapeutics Inc.
DNLI
President and CEO
2,309
0.0016%
$22.59$52,160-11.93%
2023-08-10SaleDenali Therapeutics Inc.
DNLI
President and CEO
2,526
0.0019%
$25.03$63,226-15.51%
2023-04-21SaleDenali Therapeutics Inc.
DNLI
President and CEO
24,800
0.0182%
$25.15$623,720-14.85%
2023-04-20SaleDenali Therapeutics Inc.
DNLI
President and CEO
200
0.0001%
$25.00$5,000-13.72%
2023-02-13SaleDenali Therapeutics Inc.
DNLI
President and CEO
33,815
0.0247%
$30.08$1.02M-22.72%
2023-02-10SaleDenali Therapeutics Inc.
DNLI
President and CEO
25,000
0.0183%
$29.10$727,500-19.84%
2023-02-09SaleDenali Therapeutics Inc.
DNLI
President and CEO
3,433
0.0026%
$30.59$105,015-22.18%
2023-01-05SaleDenali Therapeutics Inc.
DNLI
President and CEO
4,800
0.0035%
$28.44$136,512-15.52%
2023-01-04SaleDenali Therapeutics Inc.
DNLI
President and CEO
5,029
0.0037%
$28.73$144,483-15.95%
2022-08-19SaleDenali Therapeutics Inc.
DNLI
President and CEO
2,404
0.002%
$33.22$79,861-12.43%
2022-02-11SaleDenali Therapeutics Inc.
DNLI
President and CEO
9,491
0.0077%
$34.72$329,528-13.24%
Total: 67
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.